MoonLake Immunotherapeutics (MLTX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    MoonLake Immunotherapeuti...

    NASDAQ: MLTX · Real-Time Price · USD
    61.99
    5.61 (9.95%)
    At close: Sep 26, 2025, 3:59 PM
    61.96
    -0.05%
    After-hours: Sep 26, 2025, 07:55 PM EDT

    MoonLake Immunotherapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -28.62 -82.39 -4.78 -1.45
    PEG Ratio
    		 -0.18 1.23 0.07 -0.00
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 7.62 5.98 6.30 -6.66
    P/FCF Ratio
    		 -29.07 -68.89 -5.51 -2.2
    P/OCF Ratio
    		 -29.2 -69.35 -5.52 -2.2
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.01 0.01 0.01 -1.29
    Quick Ratio
    		 21.11 51.59 9.98 0.39
    Current Ratio
    		 21.11 51.59 9.98 0.46
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.27 -0.07 -1.32 4.61
    Return on Assets
    		 -0.25 -0.07 -0.84 -5.54
    Return on Invested Capital
    		 -0.31 -0.1 -0.94 -14.91
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist